Do you own the FTSE 100’s best performing stocks?

Edward Sheldon looks at the top performing FTSE 100 stocks. Does your portfolio contain these companies?

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Today I look at the top performing FTSE 100 stocks from a one, three and five year perspective.  There’s no doubt the results throw up a few surprises.  Does your portfolio contain any of these stocks?

One year top performers

Over the last 12 months, the best performing stocks have been Fresnillo (+95%), Randgold Resources Limited (+66%), Paddy Power Betfair (+60%), Admiral Group (+46%) and Mediclinic International (+43%).

This is certainly a diverse selection of stocks and there’s every chance that investors who own a portfolio of ‘mainstream’ popular stocks might not own any of these stocks.

Fresnillo and Randgold Resources produce silver and gold, respectively, and their share prices have clearly been boosted by the market uncertainty over the last year. Indeed, on the back of the EU referendum result on Friday, Randgold spiked 28% higher, while Fresnillo jumped 12%.

Paddy Power Betfair has steamed ahead after the merger, while Admiral Group has enjoyed strong momentum after lifting its dividend by 16% for FY2015.

Mediclinic International has likely gone under the radar for many investors since joining the FTSE 100 in March. But with revenues forecast to power ahead over the next two years, it’s no surprise this stock is on the top performer’s list.

Three year stars

On a three year view, the best performing stocks on an annualised basis have been Hikma Pharmaceuticals (+37%pa) , DCC (+37%pa), Mediclinic International (+35%pa), London Stock Exchange Group (+30%pa) and Shire (+28%pa).

Once again, several of these stocks are not mainstream ones. Furthermore, many have been promoted into the FTSE 100 quite recently, which illustrates the importance of looking outside the FTSE 100 when looking for growth opportunities.

Headquartered in Jordan, Hikma joined the FTSE 100 for the first time last year, before being demoted from the index in March and then re-entering the index earlier this month. The company has an excellent record of generating strong shareholder returns and could certainly provide an alternative to the larger slow-burning healthcare stocks such as GlaxoSmithKline.

International sales, marketing, distribution and business support services group DCC has seen strong earnings growth in the last few years and the company’s promotion to the FTSE 100 in December last year has clearly generated extra interest in the stock.

London Stock Exchange Group jumped after acquisition interest from Deutsche Bourse earlier this year, although this merger may clearly face challenges after the recent Brexit vote.

Shire makes the ‘three year best performing’ list despite the company’s share price falling from over 5,700p in August last year to 4,100p today.

Five years champions

Lastly, over a five year period, the top performing stocks on an annualised basis are Ashtead Group (+47%pa), Barratt Developments (+34%pa), easyJet (+34%pa), Taylor Wimpey (+34%) and Persimmon (+33%pa).

There’s a clear theme here, with property development stocks taking three of the top five positions, even after all three companies were hit heavily on Friday after the EU referendum result.

International equipment rental group Ashtead claims the top spot after enjoying fantastic growth in earnings over the last five years, although it was starting from a low base after the Global Financial Crisis.

EasyJet joins makes the top five after seeing earnings rise dramatically in the last five years.  

Edward Sheldon owns shares in GlaxoSmithKline. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Calendar showing the date of 5th April on desk in a house
Investing Articles

3 things to do right now as the annual ISA deadline looms!

With the ISA contribution deadline less than three weeks away, our writer runs through a trio of things he has…

Read more »

piggy bank, searching with binoculars
Growth Shares

It could be a once-in-a-decade opportunity to buy this cheap FTSE 250 stock

Jon Smith points out a FTSE 250 stock he's weighing up as to whether it could be a rare opportunity…

Read more »

Close-up image depicting a woman in her 70s taking British bank notes from her colourful leather wallet.
Investing Articles

At over 10%, I couldn’t resist this FTSE 250 share’s yield!

Christopher Ruane explains why he has bought into a 10%+ yielding FTSE 250 income share that the market has lately…

Read more »

Investor looking at stock graph on a tablet with their finger hovering over the Buy button
Investing Articles

Jim Cramer is bullish on NIO stock at $5! Should I buy it for my ISA?

NIO stock is trading 26% lower than a few months ago, despite just posting a historic quarter. It it time…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing Articles

How much do you really need in an ISA to earn a £20,000 passive income

Looking for ways to earn reliable passive income in an ISA? Our writer explores the path to five-figure earnings.

Read more »

Front view of aircraft in flight.
Investing Articles

The Rolls-Royce share price has now fallen 15%. Time to consider buying?

The Rolls-Royce share price is experiencing some turbulence at the moment. Is this a buying opportunity or will there be…

Read more »

Night Takeoff Of The American Space Shuttle
Investing Articles

Should I buy Nasdaq stock Micron for my ISA after blowout Q2 earnings?

Nasdaq tech stock Micron is generating incredible revenue growth at the moment amid the AI boom. Yet it still looks…

Read more »

Hand flipping wooden cubes for change wording" Panic" to " Calm".
Investing Articles

Is it time to dump my shares ahead of an almighty stock market crash? Nah!

How should we cope with growing fears of a stock market crash? 'Keep Calm and Carry On' worked in 1939,…

Read more »